|
Category Archives: AZBio News
Tucson High Schoolers to Explore Careers in Medicine, Other Health Professions, Feb. 20
Local high school students will practice their health-care skills, such as CPR and ultrasound imaging, during “A Pathway to Success,” an interactive health-care career fair spearheaded by residents at the University of Arizona College of Medicine – Tucson South Campus.Continue reading
GT Medical Technologies Announces $10 Million Financing to Support Launch of Targeted Therapy for Patients with Recurrent Brain Tumors
– Company is Focused on Slowing Brain Tumor Progression, Improving Quality of Life for Patients and Caregivers
– Seasoned Life Science Industry Executives Prattipati Laxminarain and Mara Aspinall Join Board of DirectorsContinue reading
Tucson Entrepreneurs Launch Second Fund to Advance UA-Related Startups
UAVenture Capital has launched a second venture capital fund designed specifically to help finance the commercialization of emerging and disruptive technologies formulated by UA researchers, faculty and students.Continue reading
Axolotl Biologix Launches New DualGraft™ For Faster Healing
Regenerative Medicine Patch Advances Wound RepairContinue reading
Natural cancer killers: ASU Biodesign researcher enhances ability of immune system
Cancer remains a leading cause of death globally and is the focus of exhaustive and varied medical research. Many of Arizona State University’s Biodesign Institute researchers are working to establish alternative therapies that sidestep the harmful effects of chemotherapy and radiation while improving the success rate for the more difficult-to-treat cancers.Continue reading
Anti-Cancer Immune Response may be Boosted with Combination Therapy, UA Cancer Center Lab Helps Discover
The University of Arizona Cancer Center collaborated with researchers at the Medical University of South Carolina to uncover better ways to harness the immune system to fight cancer.Continue reading
bioSyntagma Awarded “Best Oncology-Focused Precision Medicine Company 2018″
bioSyntagma has been awarded “Best Oncology-Focused Precision Medicine Company 2018” by Global Health and Pharma, a UK-based publication that recognizes global companies for improving public health, enhancing patient care, and lowering healthcare costs. This award follows several commercial milestones with strategic partners and Big Pharma using bioSyntagma’s beta-instruments to offer biomarker discovery services.Continue reading
Getting Ready for Tax Time – IRS Tips
The IRS information in this post is provided as a service to AZBio Members and their families. Please feel free to share it with your teams.Continue reading